Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia 3Burkitt Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Recurrence 1Prostatic Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Biphenotypic, Acute 1Dendritic Cell Sarcoma, Interdigitating 1Cardiotoxicity 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Cyclophosphamide 29fludarabine phosphate 19Filgrastim 18Whole-Body Irradiation 15Mycophenolic Acid 15Methotrexate 15Peripheral Blood Stem Cell Transplantation 14Cytarabine 14Cyclosporine 13Busulfan 12Methylprednisolone 10Thiotepa 9Antilymphocyte Serum 9Tacrolimus 8Granulocyte Colony-Stimulating Factor 8Clofarabine 8Vincristine 7Radiotherapy 7Melphalan 7Cord Blood Stem Cell Transplantation 7fludarabine 6Leucovorin 6Dexamethasone 6merphos 5Mercaptopurine 5Etoposide 5Daunorubicin 5Cladribine 5Therapeutics 4Prednisone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Biphenotypic, Acute × hydrocortisone hemisuccinate × Clear all
NCT02828358 2025-02-27

Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

National Cancer Institute (NCI)

Phase 2 Completed
78 enrolled 15 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡